Cryptic 3’ splice sites 10—30 bp upstream of canonical 3’ splice sites are used in SFBB1 mutants | A splice junction is considered differentially used between mutant and wild-type samples if the expression level of that junction differs significantly after accounting for overall expression differences of the corresponding gene locus. |
Cryptic 3’ splice sites 10—30 bp upstream of canonical 3’ splice sites are used in SFBB1 mutants | We identified 1,749 junctions that were significantly differentially used between the SF3BI mutant and SF3BI wild-type samples across the three tumor types including 1,330 novel junctions, of which 1,117 are novel 3’SSs (BH-adjusted p < 0.1, 82 File). |
Cryptic 3’ splice sites 10—30 bp upstream of canonical 3’ splice sites are used in SFBB1 mutants | All of the 619 proximal cryptic 3’SSs were used more often in the SF3BI mutant samples compared to the wild-type sam) and the novel junctions were enriched for novel 3’SSs ) showing that SF3BI mutations result in the usage of a large number of ples and 58% were out-of-frame relative to the nearby canonical 3’SSs, suggesting that these are not canonical 3’SSs missing from Gencode. |
Cryptic 3’SSs are used infrequently relative to canonical 3’SSs | that allows for more accurate quantification of splicing and because the distribution of well-characterized low and high-risk CLL prognostic factors was similar between the SF3BI mutated and wild-type samples (Fig. |
Cryptic 3’SSs are used infrequently relative to canonical 3’SSs | We observed that some cryptic 3’SSs are used exclusively in SF3BI mutants while others are also used in SF3BI wild-type samples but at a lower frequency relative to the mutants (Fig. |
Cryptic 3’SSs are used infrequently relative to canonical 3’SSs | To investigate the potential role of NMD, we identified differentially expressed genes between the SF3BI mutant and wild-type samples in a joint analysis of all three cancers and performed a gene set enrichment analysis. |
Discussion | We found that while the cryptic 3’SSs are used more often in the SF3BI mutated samples compared to wild-type samples, they are used relatively infrequently (< 10%) compared to nearby canonical 3’SSs. |
Introduction | Prior studies have shown that mutated SF3BI CLL samples have differential exon inclusion and use some cryptic 3’ splice sites (3’SSs) relative to wild-type SF3BI CLL samples [5,6,8,10,11]. |
Introduction | To test this, we examined splice site usage in transcriptome data from SF3BI mutant and SF3BI wild-type CLL, UM and BRCA cases. |
FtsZ polymerization improves the P0190723 pocket score | We conducted MD simulations of GDP-bound dimers of wild-type SaFtsZ (Fig. |
FtsZ polymerization improves the P0190723 pocket score | In the subunits of the wild-type dimer, we observed a statistically significant difference (t-test, p < 2.2e-16) in pocket scores, with the subunit with the pocket closest to the dimer interface having a better similarity score to the SaFtsZ-PC190723 co-crystal (Fig. |
FtsZ polymerization improves the P0190723 pocket score | No such difference was evident in the PC190723-resis-tant G193D mutant dimer; both subunits had pocket scores throughout the trajectory that were similar to those of a wild-type subunit with a pocket away from the dimer interface |
Introduction | Similarity scores computed from the coordinates of all-atom MD simulations preserved the ranking order determined by their static crystal structures counterparts, with PC190723-resistant SaFtsZ mutants harboring pockets that were less similar to the SaFtsZ-PC190723 co-crystal than wild-type SaFtsZ pockets. |
Introduction | Finally, FtsZ polymerization increased the pocket similarity of wild-type SaFtsZ to the SaFtsZ-PC190723 co-crystal, but not that of a PC190723-resistant mutant. |
Resistance mutations substantially reduce P0190723 pocket scores | We therefore compared the pockets of wild-type SaFtsZ with those of the PC190723-resistant mutants G193D, G196C, and N263K [12]. |
Resistance mutations substantially reduce P0190723 pocket scores | For example, over the simulation trajectory of the wild-type SaFtsZ monomer, an average of 17 out of the 20 residues contributed to the similarity score at any given time point during the simulation, resulting in an overall shift in the PocketFEATURE score to less negative values (decreased similarity). |
Resistance mutations substantially reduce P0190723 pocket scores | All three SaFtsZ mutant monomers had significantly worse pocket scores in comparisons with the SaFtsZ-PC190723 co-crystal than a wild-type monomer, and similar scores to that of |
Cardiolipin (CL) binding sites on the UraA transporter | 3 and were reproducible in the repeat CG-MD simulations performed with the wild-type UraA. |
Cardiolipin (CL) binding sites on the UraA transporter | All the simulations with the mutated forms of UraA were initiated by replacing the wild-type protein with the mutated form of the protein after the exchange of lipids step as described in the Methods section. |
Coarse-grained molecular dynamics simulations | In these simulations, after the exchange of the lipids, the wild-type form of UraA was replaced by the mutated form and 10 individual repeat production simulations of 1 us each were performed for each mutant. |